VU 0357017 hydrochloride

CAS No. 1135242-13-5

VU 0357017 hydrochloride ( VU0357017, VU-0357017, VU 0357017, CID 25010775 )

Catalog No. M17152 CAS No. 1135242-13-5

VU 0357017 hydrochloride is highly selective M1 agonists act at an allosteric site to activate the receptor (EC50: 477 ± 172 nM; Pec50: 6.37 ± 0.15).

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 37 In Stock
5MG 60 In Stock
10MG 97 In Stock
25MG 191 In Stock
50MG 284 In Stock
100MG 422 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VU 0357017 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    VU 0357017 hydrochloride is highly selective M1 agonists act at an allosteric site to activate the receptor (EC50: 477 ± 172 nM; Pec50: 6.37 ± 0.15).
  • Description
    VU0357017, also known as CID 25010775, is a subtype-selective M1 muscarinic acetylcholine allosteric agonist.
  • Synonyms
    VU0357017, VU-0357017, VU 0357017, CID 25010775
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    M1 mAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1135242-13-5
  • Formula Weight
    369.89
  • Molecular Formula
    C18H28ClN3O3
  • Purity
    98%
  • Solubility
    DMSO : ≥ 33 mg/mL 89.22 mM
  • SMILES
    CCOC(=O)N1CCC(CC1)NCCNC(=O)c1ccccc1C.Cl
  • Chemical Name
    4-[[2-[(2-methylbenzoyl)amino]ethyl]amino]-1-piperidinecarboxylic acid ethyl ester, monohydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Digby GJ, et al. ACS Chem Neurosci. 2012 Dec 19;3(12):1025-36.
molnova catalog
related products
  • Allicin

    Allicin exerts antioxidant, bactericidal, anti-cancer, anti-inflammatory activities, it exerts an inhibitory immunomodulatory effect on intestinal epithelial cells.

  • Somatostatin 1-28

    Somatostatin receptor agonist, derived from the post-translational cleavage of prosomatostatin.

  • Cerdulatinib hydroch...

    Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively.